Placebo in combination with Cytarabine Injection
MB-108
Phase 3 small_molecule active
Quick answer
Placebo in combination with Cytarabine Injection for Acute Myeloid Leukaemia (AML) is a Phase 3 program (small_molecule) at Moleculin Biotech with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Moleculin Biotech
- Indication
- Acute Myeloid Leukaemia (AML)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active